Immunocore Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,683	1,754	1,476	3,378	2,734	1,501
Market Cap Growth	13.66%	18.83%	-56.30%	23.54%	82.12%	-
Enterprise Value	1,245	1,297	1,056	3,019	2,430	1,242
Last Close Price	32.36	34.71	29.50	68.32	57.07	34.24
PS Ratio	4.18	4.39	4.76	13.54	15.68	41.15
PB Ratio	4.30	4.60	4.09	9.16	8.07	6.46
P/TBV Ratio	4.39	4.60	4.09	9.16	8.07	6.46
P/FCF Ratio	-	-	70.66	-	-	-
P/OCF Ratio	-	-	56.64	1148.85	-	-
EV/Sales Ratio	3.11	3.24	3.40	12.11	13.93	34.05
EV/FCF Ratio	-	-	50.54	-	-	-
Debt / Equity Ratio	1.15	1.15	1.20	0.23	0.24	0.37
Debt / FCF Ratio	-	-	20.72	-	-	-
Net Debt / Equity Ratio	-1.12	-1.12	-1.07	-0.97	-0.95	-1.01
Net Debt / EBITDA Ratio	19.12	19.12	8.04	6.33	6.92	1.41
Net Debt / FCF Ratio	28.40	28.40	-18.56	143.91	6.24	1.63
Asset Turnover	0.39	0.39	0.39	0.44	0.37	0.11
Inventory Turnover	2.28	2.28	2.11	2.89	-	-
Quick Ratio	3.91	3.91	4.26	3.63	4.56	4.17
Current Ratio	4.04	4.04	4.38	3.80	4.70	4.29
Return on Equity (ROE)	-9.58%	-9.58%	-14.01%	-15.62%	-18.40%	-117.20%
Return on Assets (ROA)	-1.54%	-1.54%	-4.08%	-6.73%	-6.91%	-32.31%
Return on Invested Capital (ROIC)	-	-	-	-416.02%	-713.57%	-
Return on Capital Employed (ROCE)	-3.10%	-3.10%	-6.60%	-13.20%	-12.10%	-53.60%
Earnings Yield	-2.12%	-2.02%	-3.46%	-1.64%	-1.92%	-11.99%
FCF Yield	-0.90%	-0.86%	1.42%	-0.07%	-1.88%	-9.63%
Buyback Yield / Dilution	-0.71%	-0.71%	-2.25%	-6.94%	-7.59%	-60.19%

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q